The biggest news about small cell lung cancer (SCLC) in the last 15 years is that there’s been no news at all. No improvement in survival rates, no new treatments approved1 and, making up only about 10 to 15 percent of all lung cancers2, conversations around the topic until recently were limited. This aggressive form of lung cancer almost exclusively impacts smokers or former smokers and has a devastatingly low five-year survival rate of about two percent.3
Here are five reasons why SCLC is difficult to treat and ways researchers are trying to break the slow news cycle:
1. Screening is uncommon
Unlike mammograms that screen for breast cancer and colonoscopies to screen for colon cancer, there is no widespread screening process for lung cancer.